Deep 6 immediately expanded its AI-driven clinical trials acceleration software to accurately detect evidence of SARS-CoV-2 across its hospital partners’ rapidly growing patient data. This helps researchers on the front lines of the crisis find patients for the many clinical trials that are required to bring a COVID-19 vaccine to market, as soon and as safely possible.
An affiliate of the U.S. Chamber of Commerce